These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12719922)

  • 1. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma.
    Schiepers C; Filmont JE; Czernin J
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S82-8. PubMed ID: 12719922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation surveillance strategies for patients with lymphoma.
    Cohen JB; Kurtz DM; Staton AD; Flowers CR
    Future Oncol; 2015; 11(13):1977-91. PubMed ID: 26161931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
    Mhlanga J; Alazraki A; Cho SY; Lai H; Nadel H; Pandit-Taskar N; Qi J; Rajderkar D; Voss S; Watal P; McCarten K
    Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29968. PubMed ID: 36114654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic non-Hodgkin's lymphoma initially presenting as a bladder mass.
    Gupta NK; Pal DK
    Urol Ann; 2017; 9(3):285-287. PubMed ID: 28794600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.
    Hong CM; Lee SW; Lee HJ; Song BI; Kim HW; Kang S; Jeong SY; Ahn BC; Lee J; Chae YS
    Nucl Med Mol Imaging; 2011 Mar; 45(1):76-8. PubMed ID: 24899982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cancer treatment in the abdomen: Trends and advances.
    Peungjesada S; Chuang HH; Prasad SR; Choi H; Loyer EM; Bronstein Y
    World J Radiol; 2013 Mar; 5(3):126-42. PubMed ID: 23671749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of software-based image fusion of computed tomography and F18-FDG PET scans in patients with malignant lymphoma.
    Henninger B; Putzer D; Kendler D; Uprimny C; Virgolini I; Gunsilius E; Bale R
    ScientificWorldJournal; 2012; 2012():821694. PubMed ID: 22654631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.
    Tseng D; Rachakonda LP; Su Z; Advani R; Horning S; Hoppe RT; Quon A; Graves EE; Loo BW; Tran PT
    Radiat Oncol; 2012 Jan; 7():5. PubMed ID: 22260710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma presenting as a primary bladder tumor: a case report.
    Díaz-Peromingo JA; Tato-Rodríguez J; Pesqueira-Fontán PM; Molinos-Castro S; Gayol-Fernández MC; Struzik JP
    J Med Case Rep; 2010 Apr; 4():114. PubMed ID: 20420660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging.
    Gao X; Xue Z; Xing J; Lee DY; Gottschalk SM; Heslop HE; Bollard CM; Wong ST
    Acad Radiol; 2010 Apr; 17(4):479-88. PubMed ID: 20060747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Will Rogers phenomenon and its impact on imaging diagnostics].
    Golder WA
    Radiologe; 2009 Apr; 49(4):348-54. PubMed ID: 18709345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.
    Kasamon YL; Wahl RL
    Curr Opin Oncol; 2008 Mar; 20(2):206-19. PubMed ID: 18300772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer.
    Basu S; Alavi A
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):1-4. PubMed ID: 17828536
    [No Abstract]   [Full Text] [Related]  

  • 14. PET/CT in paediatrics: it is time to increase its use!
    Roca I; Simó M; Sábado C; de Toledo JS
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):628-629. PubMed ID: 17235528
    [No Abstract]   [Full Text] [Related]  

  • 15. Is PET-CT the only option?
    Alavi A; Mavi A; Basu S; Fischman A
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):819-21. PubMed ID: 17216469
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    la Fougère C; Hundt W; Bröckel N; Pfluger T; Haug A; Scher B; Hacker M; Hahn K; Reiser M; Tiling R
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1417-25. PubMed ID: 16858568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.
    Hernandez-Pampaloni M; Takalkar A; Yu JQ; Zhuang H; Alavi A
    Pediatr Radiol; 2006 Jun; 36(6):524-31. PubMed ID: 16622665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical role of CT/PET in oncology: an update.
    Francis IR; Brown RK; Avram AM
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S68-75. PubMed ID: 16361139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent.
    Stopar TG; Mlinaric-Rascan I; Fettich J; Hojker S; Mather SJ
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):53-9. PubMed ID: 16172899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case.
    Bokstein F; Goor O; Shihman B; Rochkind S; Even-Sapir E; Metser U; Neufeld M
    J Neurooncol; 2005 Apr; 72(2):163-7. PubMed ID: 15925997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.